

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 4.80459833 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.80459833 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 4.69438218 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.69438218 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 4.51374494 |
| 6 | lysine metabolic process (GO:0006553) | 4.48426819 |
| 7 | lysine catabolic process (GO:0006554) | 4.48426819 |
| 8 | hemidesmosome assembly (GO:0031581) | 4.46802406 |
| 9 | negative regulation of cell size (GO:0045792) | 4.33166407 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.21083683 |
| 11 | regulation of cholesterol homeostasis (GO:2000188) | 4.15928058 |
| 12 | adherens junction assembly (GO:0034333) | 4.14247585 |
| 13 | kynurenine metabolic process (GO:0070189) | 4.10147902 |
| 14 | cysteine metabolic process (GO:0006534) | 4.09759283 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 4.08596579 |
| 16 | urea cycle (GO:0000050) | 4.07320792 |
| 17 | urea metabolic process (GO:0019627) | 4.07320792 |
| 18 | cell-substrate adherens junction assembly (GO:0007045) | 4.06614865 |
| 19 | focal adhesion assembly (GO:0048041) | 4.06614865 |
| 20 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.06361547 |
| 21 | cell-substrate junction assembly (GO:0007044) | 4.01042224 |
| 22 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 4.00537482 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.97600048 |
| 24 | regulation of early endosome to late endosome transport (GO:2000641) | 3.91068792 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 3.86044358 |
| 26 | glyoxylate metabolic process (GO:0046487) | 3.81010375 |
| 27 | protein localization to endosome (GO:0036010) | 3.80904635 |
| 28 | desmosome organization (GO:0002934) | 3.78585110 |
| 29 | glutamate metabolic process (GO:0006536) | 3.77563603 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 3.76766254 |
| 31 | muscle filament sliding (GO:0030049) | 3.68094177 |
| 32 | actin-myosin filament sliding (GO:0033275) | 3.68094177 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 3.68011644 |
| 34 | activation of Rac GTPase activity (GO:0032863) | 3.66935377 |
| 35 | 2-oxoglutarate metabolic process (GO:0006103) | 3.66175008 |
| 36 | aspartate family amino acid catabolic process (GO:0009068) | 3.64998440 |
| 37 | bile acid biosynthetic process (GO:0006699) | 3.64812551 |
| 38 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.57920065 |
| 39 | tryptophan catabolic process (GO:0006569) | 3.56632586 |
| 40 | indole-containing compound catabolic process (GO:0042436) | 3.56632586 |
| 41 | indolalkylamine catabolic process (GO:0046218) | 3.56632586 |
| 42 | negative regulation of sterol transport (GO:0032372) | 3.56289896 |
| 43 | negative regulation of cholesterol transport (GO:0032375) | 3.56289896 |
| 44 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.56009682 |
| 45 | high-density lipoprotein particle remodeling (GO:0034375) | 3.51973854 |
| 46 | complement activation, alternative pathway (GO:0006957) | 3.49476936 |
| 47 | cellular modified amino acid catabolic process (GO:0042219) | 3.49431271 |
| 48 | protein carboxylation (GO:0018214) | 3.46285864 |
| 49 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.46285864 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 3.45374817 |
| 51 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.44864522 |
| 52 | homocysteine metabolic process (GO:0050667) | 3.43132299 |
| 53 | regulation of protein activation cascade (GO:2000257) | 3.42780451 |
| 54 | skeletal muscle contraction (GO:0003009) | 3.41389842 |
| 55 | creatine metabolic process (GO:0006600) | 3.38007872 |
| 56 | protein retention in ER lumen (GO:0006621) | 3.37061809 |
| 57 | regulation of fibrinolysis (GO:0051917) | 3.36998529 |
| 58 | fatty acid transmembrane transport (GO:1902001) | 3.35642779 |
| 59 | NADH metabolic process (GO:0006734) | 3.35632399 |
| 60 | COPI coating of Golgi vesicle (GO:0048205) | 3.34852539 |
| 61 | Golgi transport vesicle coating (GO:0048200) | 3.34852539 |
| 62 | apoptotic process involved in morphogenesis (GO:0060561) | 3.33323868 |
| 63 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.33067479 |
| 64 | regulation of triglyceride catabolic process (GO:0010896) | 3.32925375 |
| 65 | serine family amino acid catabolic process (GO:0009071) | 3.32887491 |
| 66 | carnitine shuttle (GO:0006853) | 3.30982261 |
| 67 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.30159334 |
| 68 | tryptophan metabolic process (GO:0006568) | 3.26622799 |
| 69 | semaphorin-plexin signaling pathway (GO:0071526) | 3.25902515 |
| 70 | proline biosynthetic process (GO:0006561) | 3.24340715 |
| 71 | epithelial cell-cell adhesion (GO:0090136) | 3.23105482 |
| 72 | regulation of complement activation (GO:0030449) | 3.22027734 |
| 73 | drug catabolic process (GO:0042737) | 3.21628608 |
| 74 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.20909279 |
| 75 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.20494488 |
| 76 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.19880992 |
| 77 | reverse cholesterol transport (GO:0043691) | 3.19755523 |
| 78 | acetyl-CoA metabolic process (GO:0006084) | 3.19363550 |
| 79 | positive regulation of lipid catabolic process (GO:0050996) | 3.18938306 |
| 80 | alpha-amino acid catabolic process (GO:1901606) | 3.18611320 |
| 81 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.15684937 |
| 82 | acylglycerol homeostasis (GO:0055090) | 3.15064353 |
| 83 | triglyceride homeostasis (GO:0070328) | 3.15064353 |
| 84 | bile acid metabolic process (GO:0008206) | 3.13179541 |
| 85 | amino-acid betaine transport (GO:0015838) | 3.12144613 |
| 86 | carnitine transport (GO:0015879) | 3.12144613 |
| 87 | positive regulation of myotube differentiation (GO:0010831) | 3.11874393 |
| 88 | cellular ketone body metabolic process (GO:0046950) | 3.11434005 |
| 89 | plasma lipoprotein particle clearance (GO:0034381) | 3.10686217 |
| 90 | positive regulation of synapse maturation (GO:0090129) | 3.05314340 |
| 91 | short-chain fatty acid metabolic process (GO:0046459) | 3.04846400 |
| 92 | carnitine transmembrane transport (GO:1902603) | 3.04004605 |
| 93 | phospholipid homeostasis (GO:0055091) | 3.03169968 |
| 94 | cellular amino acid catabolic process (GO:0009063) | 3.01455719 |
| 95 | ethanol oxidation (GO:0006069) | 2.95963601 |
| 96 | valine metabolic process (GO:0006573) | 2.95568192 |
| 97 | actin-mediated cell contraction (GO:0070252) | 2.95230458 |
| 98 | response to mercury ion (GO:0046689) | 2.91024289 |
| 99 | phospholipid efflux (GO:0033700) | 2.90594098 |
| 100 | regulation of fatty acid oxidation (GO:0046320) | 2.89709899 |
| 101 | protein-lipid complex remodeling (GO:0034368) | 2.89263784 |
| 102 | macromolecular complex remodeling (GO:0034367) | 2.89263784 |
| 103 | plasma lipoprotein particle remodeling (GO:0034369) | 2.89263784 |
| 104 | fatty acid beta-oxidation (GO:0006635) | 2.87056538 |
| 105 | endothelial cell chemotaxis (GO:0035767) | 2.86688236 |
| 106 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.86186278 |
| 107 | exogenous drug catabolic process (GO:0042738) | 2.86045105 |
| 108 | positive regulation of fatty acid oxidation (GO:0046321) | 2.85881224 |
| 109 | coenzyme catabolic process (GO:0009109) | 2.85590832 |
| 110 | negative regulation of fatty acid transport (GO:2000192) | 2.83565257 |
| 111 | 4-hydroxyproline metabolic process (GO:0019471) | 2.83303403 |
| 112 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.81881227 |
| 113 | carnitine metabolic process (GO:0009437) | 2.79827363 |
| 114 | drug transmembrane transport (GO:0006855) | 2.79228243 |
| 115 | aromatic amino acid family metabolic process (GO:0009072) | 2.77867668 |
| 116 | fatty acid oxidation (GO:0019395) | 2.77641368 |
| 117 | protein-lipid complex assembly (GO:0065005) | 2.76548363 |
| 118 | striated muscle contraction (GO:0006941) | 2.75783419 |
| 119 | dicarboxylic acid catabolic process (GO:0043649) | 2.74217141 |
| 120 | phosphate ion transmembrane transport (GO:0035435) | 2.73990352 |
| 121 | tricarboxylic acid metabolic process (GO:0072350) | 2.72119208 |
| 122 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.71571333 |
| 123 | barbed-end actin filament capping (GO:0051016) | 2.71522064 |
| 124 | lipid oxidation (GO:0034440) | 2.71355964 |
| 125 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.70577247 |
| 126 | plasma membrane repair (GO:0001778) | 2.70507474 |
| 127 | fatty acid homeostasis (GO:0055089) | 2.69530632 |
| 128 | maternal placenta development (GO:0001893) | 2.69382279 |
| 129 | quaternary ammonium group transport (GO:0015697) | 2.69223771 |
| 130 | skeletal muscle fiber development (GO:0048741) | 2.68629548 |
| 131 | sarcomere organization (GO:0045214) | 2.68562475 |
| 132 | monocarboxylic acid catabolic process (GO:0072329) | 2.68340626 |
| 133 | cardiac muscle contraction (GO:0060048) | 2.67416740 |
| 134 | fatty acid catabolic process (GO:0009062) | 2.67256242 |
| 135 | plasma lipoprotein particle assembly (GO:0034377) | 2.66639528 |
| 136 | macroautophagy (GO:0016236) | 2.64799619 |
| 137 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.64773499 |
| 138 | regulation of bile acid biosynthetic process (GO:0070857) | 2.64673518 |
| 139 | protein targeting to plasma membrane (GO:0072661) | 2.64497911 |
| 140 | ketone body metabolic process (GO:1902224) | 2.64371270 |
| 141 | cholesterol efflux (GO:0033344) | 2.64148932 |
| 142 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.63923245 |
| 143 | basement membrane organization (GO:0071711) | 2.63665774 |
| 144 | cell-cell junction maintenance (GO:0045217) | 2.62805911 |
| 145 | negative regulation of lipid transport (GO:0032369) | 2.62411371 |
| 146 | oxaloacetate metabolic process (GO:0006107) | 2.62359450 |
| 147 | serine family amino acid metabolic process (GO:0009069) | 2.62243794 |
| 148 | skeletal muscle adaptation (GO:0043501) | 2.60318405 |
| 149 | gluconeogenesis (GO:0006094) | 2.60171102 |
| 150 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.59429002 |
| 151 | regulation of skeletal muscle contraction (GO:0014819) | 2.58922270 |
| 152 | skin morphogenesis (GO:0043589) | 2.58452476 |
| 153 | activation of MAPKKK activity (GO:0000185) | 2.58358715 |
| 154 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.57270494 |
| 155 | negative regulation of striated muscle cell differentiation (GO:0051154) | 2.55945633 |
| 156 | response to muscle activity (GO:0014850) | 2.55885103 |
| 157 | cardiac myofibril assembly (GO:0055003) | 2.55749754 |
| 158 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.55268806 |
| 159 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.55100793 |
| 160 | sodium ion export (GO:0071436) | 2.53920829 |
| 161 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.53403605 |
| 162 | myofibril assembly (GO:0030239) | 2.52914768 |
| 163 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.50119194 |
| 164 | actin filament-based movement (GO:0030048) | 2.49580356 |
| 165 | stress fiber assembly (GO:0043149) | 2.48882868 |
| 166 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.47760154 |
| 167 | positive regulation of receptor recycling (GO:0001921) | 2.44586088 |
| 168 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.44341934 |
| 169 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.42481935 |
| 170 | glycogen catabolic process (GO:0005980) | 2.41930472 |
| 171 | peptidyl-proline hydroxylation (GO:0019511) | 2.40871010 |
| 172 | negative regulation of necroptotic process (GO:0060546) | 2.39826976 |
| 173 | hexose biosynthetic process (GO:0019319) | 2.39826821 |
| 174 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.37964319 |
| 175 | atrioventricular valve morphogenesis (GO:0003181) | 2.37403715 |
| 176 | * planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.37078546 |
| 177 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.36804777 |
| 178 | proline metabolic process (GO:0006560) | 2.35411011 |
| 179 | regulation of p38MAPK cascade (GO:1900744) | 2.34526119 |
| 180 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.33036338 |
| 181 | muscle cell fate commitment (GO:0042693) | 2.32237776 |
| 182 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.31959712 |
| 183 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.30946761 |
| 184 | monosaccharide biosynthetic process (GO:0046364) | 2.29627868 |
| 185 | positive regulation of protein dephosphorylation (GO:0035307) | 2.28573785 |
| 186 | cellular protein complex localization (GO:0034629) | 2.27893165 |
| 187 | regulation of translational fidelity (GO:0006450) | 2.27776236 |
| 188 | protein hydroxylation (GO:0018126) | 2.26795768 |
| 189 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.26633748 |
| 190 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.26495414 |
| 191 | cell volume homeostasis (GO:0006884) | 2.26190147 |
| 192 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.26170058 |
| 193 | striated muscle atrophy (GO:0014891) | 2.25337357 |
| 194 | negative regulation of catenin import into nucleus (GO:0035414) | 2.25258499 |
| 195 | respiratory system process (GO:0003016) | 2.23990020 |
| 196 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.22384149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.30288460 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.50875778 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.04579514 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.74186823 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.71846536 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.82207109 |
| 7 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.81693017 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.73460040 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.16140474 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.10799204 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.04736240 |
| 12 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.04644772 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.99092532 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.97167746 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.96773639 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91925297 |
| 17 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.91646930 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.81890840 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.81010290 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.80456565 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.73506467 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.70544283 |
| 23 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.65793022 |
| 24 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61235880 |
| 25 | KDM2B_26808549_Chip-Seq_K562_Human | 1.55625722 |
| 26 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.55001329 |
| 27 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.54690538 |
| 28 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.53322654 |
| 29 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.52967398 |
| 30 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.50533746 |
| 31 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.44344045 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.42838388 |
| 33 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.42055054 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.41977174 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37426836 |
| 36 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.34919408 |
| 37 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.33438045 |
| 38 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.33006534 |
| 39 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.32973731 |
| 40 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.32923486 |
| 41 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.32392460 |
| 42 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.29634918 |
| 43 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29207905 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28453160 |
| 45 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27092324 |
| 46 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.26256861 |
| 47 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.26256861 |
| 48 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.24395480 |
| 49 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.24364343 |
| 50 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.21805045 |
| 51 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.19734457 |
| 52 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.18310848 |
| 53 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17621576 |
| 54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17399563 |
| 55 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.17161988 |
| 56 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.16577271 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15941666 |
| 58 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.15933213 |
| 59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15881367 |
| 60 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14575317 |
| 61 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14295144 |
| 62 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.14203011 |
| 63 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12875403 |
| 64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12634948 |
| 65 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12108452 |
| 66 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11646179 |
| 67 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11494270 |
| 68 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.10645565 |
| 69 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.10296911 |
| 70 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.10067571 |
| 71 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.07992253 |
| 72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07949032 |
| 73 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07387698 |
| 74 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06999649 |
| 75 | P68_20966046_ChIP-Seq_HELA_Human | 1.06834612 |
| 76 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06099111 |
| 77 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05539555 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05406918 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.05153992 |
| 80 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05127036 |
| 81 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.04964445 |
| 82 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.04832812 |
| 83 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04267408 |
| 84 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03994642 |
| 85 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.03692967 |
| 86 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03389649 |
| 87 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02943011 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02940529 |
| 89 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.02275286 |
| 90 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01425653 |
| 91 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01151455 |
| 92 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.99747171 |
| 93 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98592880 |
| 94 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98564130 |
| 95 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98321376 |
| 96 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.97616477 |
| 97 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.96759482 |
| 98 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96217355 |
| 99 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95827219 |
| 100 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.95629022 |
| 101 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.95547018 |
| 102 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.95352631 |
| 103 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.95226578 |
| 104 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.95116538 |
| 105 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.94458269 |
| 106 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.93422584 |
| 107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93249737 |
| 108 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.92672498 |
| 109 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.92665361 |
| 110 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.92632060 |
| 111 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91934501 |
| 112 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91273645 |
| 113 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90444750 |
| 114 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.88981259 |
| 115 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88096309 |
| 116 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.87185527 |
| 117 | MYC_22102868_ChIP-Seq_BL_Human | 0.86794067 |
| 118 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86449438 |
| 119 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85003718 |
| 120 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84721667 |
| 121 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84484623 |
| 122 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.83671681 |
| 123 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.83549281 |
| 124 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.82598706 |
| 125 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80719526 |
| 126 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.80552248 |
| 127 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.80482933 |
| 128 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.79461530 |
| 129 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.79309401 |
| 130 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.78795933 |
| 131 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.78550779 |
| 132 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.78228970 |
| 133 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.78183078 |
| 134 | GATA2_19941826_ChIP-Seq_K562_Human | 0.77381443 |
| 135 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.77281814 |
| 136 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.77097357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.82125251 |
| 2 | MP0005360_urolithiasis | 5.60720252 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.26012640 |
| 4 | MP0005365_abnormal_bile_salt | 4.16088637 |
| 5 | MP0005451_abnormal_body_composition | 3.51451753 |
| 6 | MP0003252_abnormal_bile_duct | 3.26456066 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.07524847 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.98483987 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.87269966 |
| 10 | MP0005083_abnormal_biliary_tract | 2.70582763 |
| 11 | MP0009840_abnormal_foam_cell | 2.42503963 |
| 12 | MP0004130_abnormal_muscle_cell | 2.29665084 |
| 13 | MP0005076_abnormal_cell_differentiation | 2.25725024 |
| 14 | MP0005332_abnormal_amino_acid | 2.15390025 |
| 15 | MP0000751_myopathy | 2.14301251 |
| 16 | MP0002877_abnormal_melanocyte_morpholog | 2.05271122 |
| 17 | MP0000678_abnormal_parathyroid_gland | 2.01771862 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 2.01495124 |
| 19 | MP0001666_abnormal_nutrient_absorption | 1.97557740 |
| 20 | MP0003453_abnormal_keratinocyte_physiol | 1.94917624 |
| 21 | MP0003195_calcinosis | 1.92840546 |
| 22 | MP0002249_abnormal_larynx_morphology | 1.92763368 |
| 23 | MP0000537_abnormal_urethra_morphology | 1.91500670 |
| 24 | MP0008961_abnormal_basal_metabolism | 1.87229659 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 1.84485314 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.82572864 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.82543462 |
| 28 | MP0005409_darkened_coat_color | 1.80442397 |
| 29 | MP0000579_abnormal_nail_morphology | 1.80113435 |
| 30 | MP0002837_dystrophic_cardiac_calcinosis | 1.78848134 |
| 31 | MP0010030_abnormal_orbit_morphology | 1.68823502 |
| 32 | MP0004859_abnormal_synaptic_plasticity | 1.68237626 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.66333677 |
| 34 | MP0000609_abnormal_liver_physiology | 1.66119334 |
| 35 | MP0004272_abnormal_basement_membrane | 1.65836918 |
| 36 | MP0004510_myositis | 1.63948872 |
| 37 | MP0000747_muscle_weakness | 1.61646682 |
| 38 | MP0005670_abnormal_white_adipose | 1.59925803 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.59436035 |
| 40 | MP0003329_amyloid_beta_deposits | 1.56664548 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.55960415 |
| 42 | MP0003646_muscle_fatigue | 1.54558012 |
| 43 | MP0004145_abnormal_muscle_electrophysio | 1.52692096 |
| 44 | MP0005666_abnormal_adipose_tissue | 1.51697439 |
| 45 | MP0004019_abnormal_vitamin_homeostasis | 1.41976501 |
| 46 | MP0005319_abnormal_enzyme/_coenzyme | 1.41896228 |
| 47 | MP0002269_muscular_atrophy | 1.40748277 |
| 48 | MP0002060_abnormal_skin_morphology | 1.37290063 |
| 49 | MP0004087_abnormal_muscle_fiber | 1.36202349 |
| 50 | MP0000467_abnormal_esophagus_morphology | 1.34221114 |
| 51 | MP0004036_abnormal_muscle_relaxation | 1.33482816 |
| 52 | MP0000762_abnormal_tongue_morphology | 1.33453374 |
| 53 | MP0005501_abnormal_skin_physiology | 1.33241862 |
| 54 | MP0008260_abnormal_autophagy | 1.32442568 |
| 55 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32369210 |
| 56 | MP0002909_abnormal_adrenal_gland | 1.32267705 |
| 57 | MP0001348_abnormal_lacrimal_gland | 1.31485189 |
| 58 | MP0003123_paternal_imprinting | 1.31410549 |
| 59 | MP0002254_reproductive_system_inflammat | 1.30881020 |
| 60 | MP0000749_muscle_degeneration | 1.30682020 |
| 61 | MP0000604_amyloidosis | 1.30595880 |
| 62 | MP0002332_abnormal_exercise_endurance | 1.28624246 |
| 63 | MP0006138_congestive_heart_failure | 1.27251721 |
| 64 | MP0000566_synostosis | 1.27208408 |
| 65 | MP0003091_abnormal_cell_migration | 1.25227237 |
| 66 | MP0002971_abnormal_brown_adipose | 1.24213129 |
| 67 | MP0001958_emphysema | 1.23207385 |
| 68 | MP0003879_abnormal_hair_cell | 1.19686588 |
| 69 | MP0005023_abnormal_wound_healing | 1.19655395 |
| 70 | MP0005375_adipose_tissue_phenotype | 1.18932296 |
| 71 | MP0004233_abnormal_muscle_weight | 1.18765386 |
| 72 | MP0003300_gastrointestinal_ulcer | 1.18199673 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.16037432 |
| 74 | MP0002089_abnormal_postnatal_growth/wei | 1.15443082 |
| 75 | MP0009643_abnormal_urine_homeostasis | 1.13852895 |
| 76 | MP0003868_abnormal_feces_composition | 1.09989891 |
| 77 | MP0005410_abnormal_fertilization | 1.09113981 |
| 78 | MP0003279_aneurysm | 1.06425995 |
| 79 | MP0003045_fibrosis | 1.05422073 |
| 80 | MP0005257_abnormal_intraocular_pressure | 1.04909578 |
| 81 | MP0004043_abnormal_pH_regulation | 1.04861439 |
| 82 | MP0005330_cardiomyopathy | 1.04306903 |
| 83 | MP0004084_abnormal_cardiac_muscle | 1.02980496 |
| 84 | MP0000759_abnormal_skeletal_muscle | 1.01322070 |
| 85 | MP0004858_abnormal_nervous_system | 1.00577648 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.97186601 |
| 87 | MP0001765_abnormal_ion_homeostasis | 0.96846789 |
| 88 | MP0002078_abnormal_glucose_homeostasis | 0.96327525 |
| 89 | MP0003283_abnormal_digestive_organ | 0.94216030 |
| 90 | MP0009053_abnormal_anal_canal | 0.90929360 |
| 91 | MP0003950_abnormal_plasma_membrane | 0.90263402 |
| 92 | MP0002822_catalepsy | 0.90192182 |
| 93 | MP0000534_abnormal_ureter_morphology | 0.89867076 |
| 94 | MP0000013_abnormal_adipose_tissue | 0.89535101 |
| 95 | MP0001346_abnormal_lacrimal_gland | 0.89290156 |
| 96 | MP0009672_abnormal_birth_weight | 0.89102991 |
| 97 | MP0005535_abnormal_body_temperature | 0.89092212 |
| 98 | MP0005334_abnormal_fat_pad | 0.88172598 |
| 99 | MP0005620_abnormal_muscle_contractility | 0.88016662 |
| 100 | MP0002972_abnormal_cardiac_muscle | 0.87992975 |
| 101 | MP0003075_altered_response_to | 0.87654503 |
| 102 | MP0000003_abnormal_adipose_tissue | 0.86695366 |
| 103 | MP0002106_abnormal_muscle_physiology | 0.86000861 |
| 104 | MP0001756_abnormal_urination | 0.83752824 |
| 105 | MP0002796_impaired_skin_barrier | 0.82398394 |
| 106 | MP0001299_abnormal_eye_distance/ | 0.81253128 |
| 107 | MP0001661_extended_life_span | 0.80911114 |
| 108 | MP0000598_abnormal_liver_morphology | 0.80593835 |
| 109 | MP0010352_gastrointestinal_tract_polyps | 0.80428672 |
| 110 | MP0000750_abnormal_muscle_regeneration | 0.79769356 |
| 111 | MP0000858_altered_metastatic_potential | 0.79106610 |
| 112 | MP0001216_abnormal_epidermal_layer | 0.78895056 |
| 113 | MP0008874_decreased_physiological_sensi | 0.76577372 |
| 114 | MP0004270_analgesia | 0.76492324 |
| 115 | MP0000733_abnormal_muscle_development | 0.73802489 |
| 116 | MP0002168_other_aberrant_phenotype | 0.72874790 |
| 117 | MP0005448_abnormal_energy_balance | 0.71944238 |
| 118 | MP0003656_abnormal_erythrocyte_physiolo | 0.71854324 |
| 119 | MP0000767_abnormal_smooth_muscle | 0.71306022 |
| 120 | MP0003942_abnormal_urinary_system | 0.71221962 |
| 121 | MP0005623_abnormal_meninges_morphology | 0.70996611 |
| 122 | MP0005647_abnormal_sex_gland | 0.70117034 |
| 123 | MP0010630_abnormal_cardiac_muscle | 0.70031518 |
| 124 | MP0010771_integument_phenotype | 0.69109796 |
| 125 | MP0005369_muscle_phenotype | 0.68429303 |
| 126 | MP0003385_abnormal_body_wall | 0.68260487 |
| 127 | MP0003634_abnormal_glial_cell | 0.67801191 |
| 128 | MP0001730_embryonic_growth_arrest | 0.67314909 |
| 129 | MP0005275_abnormal_skin_tensile | 0.66403085 |
| 130 | MP0005636_abnormal_mineral_homeostasis | 0.65921399 |
| 131 | MP0006036_abnormal_mitochondrial_physio | 0.65885234 |
| 132 | MP0000681_abnormal_thyroid_gland | 0.65496898 |
| 133 | MP0002098_abnormal_vibrissa_morphology | 0.65280650 |
| 134 | MP0004947_skin_inflammation | 0.65049077 |
| 135 | MP0009642_abnormal_blood_homeostasis | 0.62789932 |
| 136 | MP0002234_abnormal_pharynx_morphology | 0.62108755 |
| 137 | MP0002932_abnormal_joint_morphology | 0.61672400 |
| 138 | MP0009278_abnormal_bone_marrow | 0.61229175 |
| 139 | MP0003566_abnormal_cell_adhesion | 0.60820600 |
| 140 | MP0008438_abnormal_cutaneous_collagen | 0.60594710 |
| 141 | MP0005187_abnormal_penis_morphology | 0.60566144 |
| 142 | * MP0002114_abnormal_axial_skeleton | 0.60558774 |
| 143 | MP0009115_abnormal_fat_cell | 0.60330200 |
| 144 | MP0003690_abnormal_glial_cell | 0.60007581 |
| 145 | MP0002928_abnormal_bile_duct | 0.59894179 |
| 146 | MP0005508_abnormal_skeleton_morphology | 0.59860870 |
| 147 | MP0002896_abnormal_bone_mineralization | 0.58393836 |
| 148 | MP0001849_ear_inflammation | 0.57923902 |
| 149 | * MP0003635_abnormal_synaptic_transmissio | 0.57831521 |
| 150 | MP0005621_abnormal_cell_physiology | 0.56730545 |
| 151 | MP0002108_abnormal_muscle_morphology | 0.56303883 |
| 152 | MP0009931_abnormal_skin_appearance | 0.56043776 |
| 153 | MP0003959_abnormal_lean_body | 0.55819723 |
| 154 | MP0005166_decreased_susceptibility_to | 0.54868996 |
| 155 | MP0002970_abnormal_white_adipose | 0.54351045 |
| 156 | MP0002136_abnormal_kidney_physiology | 0.53457876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.85657556 |
| 2 | Nemaline bodies (HP:0003798) | 4.47568358 |
| 3 | Xanthomatosis (HP:0000991) | 4.09695155 |
| 4 | Distal lower limb amyotrophy (HP:0008944) | 4.08685650 |
| 5 | Distal lower limb muscle weakness (HP:0009053) | 3.79272490 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 3.75398906 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.65926715 |
| 8 | Exercise-induced myalgia (HP:0003738) | 3.53123021 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.51563763 |
| 10 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.48746041 |
| 11 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.34939214 |
| 12 | Protrusio acetabuli (HP:0003179) | 3.31733814 |
| 13 | Ketosis (HP:0001946) | 3.31319162 |
| 14 | Abnormality of the lower motor neuron (HP:0002366) | 3.30162635 |
| 15 | Lower limb amyotrophy (HP:0007210) | 3.25317879 |
| 16 | Complement deficiency (HP:0004431) | 3.18549744 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 3.13145467 |
| 18 | Hypobetalipoproteinemia (HP:0003563) | 3.11136894 |
| 19 | Gout (HP:0001997) | 3.11077642 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 3.02938896 |
| 21 | Difficulty running (HP:0009046) | 3.01910727 |
| 22 | Obstructive sleep apnea (HP:0002870) | 3.00122699 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.98648814 |
| 24 | Hyporeflexia of lower limbs (HP:0002600) | 2.96063740 |
| 25 | Myoglobinuria (HP:0002913) | 2.93976789 |
| 26 | Spinal rigidity (HP:0003306) | 2.87785797 |
| 27 | Hypolipoproteinemia (HP:0010981) | 2.84866050 |
| 28 | Premature rupture of membranes (HP:0001788) | 2.84674957 |
| 29 | Hyperammonemia (HP:0001987) | 2.83758831 |
| 30 | Ulnar bowing (HP:0003031) | 2.81640505 |
| 31 | Abnormality of the Achilles tendon (HP:0005109) | 2.81038083 |
| 32 | Ketoacidosis (HP:0001993) | 2.80604273 |
| 33 | Type 1 muscle fiber predominance (HP:0003803) | 2.79456989 |
| 34 | Exercise-induced muscle cramps (HP:0003710) | 2.77582155 |
| 35 | Epidermoid cyst (HP:0200040) | 2.71216644 |
| 36 | Hyperglycinuria (HP:0003108) | 2.69490760 |
| 37 | Neck muscle weakness (HP:0000467) | 2.65159708 |
| 38 | EMG: myopathic abnormalities (HP:0003458) | 2.64173442 |
| 39 | Fragile skin (HP:0001030) | 2.62925288 |
| 40 | Broad face (HP:0000283) | 2.61194771 |
| 41 | Increased connective tissue (HP:0009025) | 2.59168540 |
| 42 | Stridor (HP:0010307) | 2.57304540 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.55181374 |
| 44 | Abnormality of glycine metabolism (HP:0010895) | 2.55181374 |
| 45 | Abnormality of the common coagulation pathway (HP:0010990) | 2.52905517 |
| 46 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.50656984 |
| 47 | Cholelithiasis (HP:0001081) | 2.46389286 |
| 48 | Achilles tendon contracture (HP:0001771) | 2.43953533 |
| 49 | Shallow orbits (HP:0000586) | 2.43091778 |
| 50 | Upper limb amyotrophy (HP:0009129) | 2.39944170 |
| 51 | Distal upper limb amyotrophy (HP:0007149) | 2.39944170 |
| 52 | Hyperglycinemia (HP:0002154) | 2.39338742 |
| 53 | Prolonged partial thromboplastin time (HP:0003645) | 2.38556587 |
| 54 | Difficulty climbing stairs (HP:0003551) | 2.37641729 |
| 55 | Muscle fiber inclusion bodies (HP:0100299) | 2.37366381 |
| 56 | Myocardial infarction (HP:0001658) | 2.37247674 |
| 57 | Atrophic scars (HP:0001075) | 2.36949689 |
| 58 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.32693049 |
| 59 | Hypoglycemic coma (HP:0001325) | 2.31795989 |
| 60 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.31701834 |
| 61 | Subaortic stenosis (HP:0001682) | 2.31701834 |
| 62 | Neonatal onset (HP:0003623) | 2.28985377 |
| 63 | Bulbar palsy (HP:0001283) | 2.28759008 |
| 64 | Abnormal gallbladder physiology (HP:0012438) | 2.28075843 |
| 65 | Cholecystitis (HP:0001082) | 2.28075843 |
| 66 | Abnormality of purine metabolism (HP:0004352) | 2.27782862 |
| 67 | Abnormality of complement system (HP:0005339) | 2.27647870 |
| 68 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.27558261 |
| 69 | Abnormal gallbladder morphology (HP:0012437) | 2.25036101 |
| 70 | Distal arthrogryposis (HP:0005684) | 2.23266634 |
| 71 | Abnormality of the calf musculature (HP:0001430) | 2.22388146 |
| 72 | Muscle fiber splitting (HP:0003555) | 2.19466220 |
| 73 | Turricephaly (HP:0000262) | 2.18536175 |
| 74 | Hypercholesterolemia (HP:0003124) | 2.16797187 |
| 75 | Hyperacusis (HP:0010780) | 2.16526706 |
| 76 | Malnutrition (HP:0004395) | 2.15497825 |
| 77 | Skin nodule (HP:0200036) | 2.13222230 |
| 78 | Back pain (HP:0003418) | 2.12733831 |
| 79 | Increased variability in muscle fiber diameter (HP:0003557) | 2.12594270 |
| 80 | Abnormality of the intrinsic pathway (HP:0010989) | 2.11804221 |
| 81 | Vertebral compression fractures (HP:0002953) | 2.11425406 |
| 82 | Cerebral aneurysm (HP:0004944) | 2.10879265 |
| 83 | Spastic diplegia (HP:0001264) | 2.09779479 |
| 84 | Abnormality of the calcaneus (HP:0008364) | 2.08905516 |
| 85 | Dysmetric saccades (HP:0000641) | 2.07713804 |
| 86 | Hyperuricemia (HP:0002149) | 2.06202228 |
| 87 | Increased purine levels (HP:0004368) | 2.06202228 |
| 88 | Mitral regurgitation (HP:0001653) | 2.02118220 |
| 89 | Calcaneovalgus deformity (HP:0001848) | 2.02069028 |
| 90 | Right ventricular cardiomyopathy (HP:0011663) | 2.01850732 |
| 91 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.01277926 |
| 92 | Foot dorsiflexor weakness (HP:0009027) | 2.00977697 |
| 93 | Asymmetric septal hypertrophy (HP:0001670) | 2.00883137 |
| 94 | Hand muscle atrophy (HP:0009130) | 2.00744279 |
| 95 | Ulnar deviation of the wrist (HP:0003049) | 2.00559466 |
| 96 | Insomnia (HP:0100785) | 2.00553452 |
| 97 | Short nail (HP:0001799) | 1.99373456 |
| 98 | Generalized amyotrophy (HP:0003700) | 1.99347095 |
| 99 | Scapular winging (HP:0003691) | 1.97640737 |
| 100 | Polycythemia (HP:0001901) | 1.97432294 |
| 101 | Reticulocytosis (HP:0001923) | 1.95073546 |
| 102 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.93822084 |
| 103 | Axonal loss (HP:0003447) | 1.93435216 |
| 104 | Lymphangioma (HP:0100764) | 1.92645007 |
| 105 | Slender build (HP:0001533) | 1.92110583 |
| 106 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.90641792 |
| 107 | Round ear (HP:0100830) | 1.90357448 |
| 108 | Status epilepticus (HP:0002133) | 1.90235032 |
| 109 | Cervical subluxation (HP:0003308) | 1.89660006 |
| 110 | Bundle branch block (HP:0011710) | 1.89621371 |
| 111 | Frequent falls (HP:0002359) | 1.88968746 |
| 112 | Joint hemorrhage (HP:0005261) | 1.88945077 |
| 113 | Vascular calcification (HP:0004934) | 1.88232754 |
| 114 | Long toe (HP:0010511) | 1.87703463 |
| 115 | Abnormality of nucleobase metabolism (HP:0010932) | 1.87627128 |
| 116 | Sudden death (HP:0001699) | 1.86289329 |
| 117 | Broad metatarsal (HP:0001783) | 1.86245904 |
| 118 | Cerebral inclusion bodies (HP:0100314) | 1.86112021 |
| 119 | Calf muscle hypertrophy (HP:0008981) | 1.85065484 |
| 120 | Muscle stiffness (HP:0003552) | 1.84838193 |
| 121 | EMG: neuropathic changes (HP:0003445) | 1.84655793 |
| 122 | Late onset (HP:0003584) | 1.84396443 |
| 123 | Progressive muscle weakness (HP:0003323) | 1.84126259 |
| 124 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.83593683 |
| 125 | Hydroxyprolinuria (HP:0003080) | 1.83496704 |
| 126 | Abnormality of proline metabolism (HP:0010907) | 1.83496704 |
| 127 | Aneurysm (HP:0002617) | 1.83362524 |
| 128 | Global brain atrophy (HP:0002283) | 1.82962170 |
| 129 | Fat malabsorption (HP:0002630) | 1.82896319 |
| 130 | Abnormality of the foot musculature (HP:0001436) | 1.82647896 |
| 131 | Hepatocellular carcinoma (HP:0001402) | 1.82182302 |
| 132 | Mitral valve prolapse (HP:0001634) | 1.82082321 |
| 133 | Myopathic facies (HP:0002058) | 1.81043041 |
| 134 | Ventricular tachycardia (HP:0004756) | 1.81036311 |
| 135 | Flat acetabular roof (HP:0003180) | 1.81013416 |
| 136 | Cardiovascular calcification (HP:0011915) | 1.80794473 |
| 137 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.79616310 |
| 138 | Elfin facies (HP:0004428) | 1.79037388 |
| 139 | Renovascular hypertension (HP:0100817) | 1.78101598 |
| 140 | Rhabdomyolysis (HP:0003201) | 1.77181971 |
| 141 | Easy fatigability (HP:0003388) | 1.76443748 |
| 142 | Elbow flexion contracture (HP:0002987) | 1.75793878 |
| 143 | Disproportionate tall stature (HP:0001519) | 1.75465346 |
| 144 | Deformed tarsal bones (HP:0008119) | 1.73932150 |
| 145 | Bowed forearm bones (HP:0003956) | 1.73685490 |
| 146 | Bowing of the arm (HP:0006488) | 1.73685490 |
| 147 | Thin bony cortex (HP:0002753) | 1.72027429 |
| 148 | Trismus (HP:0000211) | 1.70758834 |
| 149 | Advanced eruption of teeth (HP:0006288) | 1.68954979 |
| 150 | Neurofibrillary tangles (HP:0002185) | 1.68399339 |
| 151 | Pterygium (HP:0001059) | 1.68249464 |
| 152 | Abnormal atrioventricular conduction (HP:0005150) | 1.67895283 |
| 153 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.66641528 |
| 154 | Thin ribs (HP:0000883) | 1.66064447 |
| 155 | Ankle clonus (HP:0011448) | 1.62885480 |
| 156 | Ragged-red muscle fibers (HP:0003200) | 1.61623064 |
| 157 | Bladder diverticulum (HP:0000015) | 1.60645865 |
| 158 | Long palpebral fissure (HP:0000637) | 1.59464191 |
| 159 | Metatarsus adductus (HP:0001840) | 1.58657445 |
| 160 | Milia (HP:0001056) | 1.57248584 |
| 161 | Ankle contracture (HP:0006466) | 1.56295575 |
| 162 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.55205577 |
| 163 | Blue sclerae (HP:0000592) | 1.55067499 |
| 164 | Abnormality of the tricuspid valve (HP:0001702) | 1.55023405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.42803187 |
| 2 | EPHA2 | 3.28325251 |
| 3 | IRAK3 | 3.05289904 |
| 4 | PKN2 | 2.99446640 |
| 5 | TTN | 2.76351244 |
| 6 | SIK1 | 2.71648176 |
| 7 | ERN1 | 2.50372528 |
| 8 | RIPK1 | 2.41635975 |
| 9 | PRPF4B | 2.40439736 |
| 10 | SMG1 | 2.36186005 |
| 11 | PDK4 | 2.22697494 |
| 12 | PDK3 | 2.22697494 |
| 13 | PRKD3 | 2.22424517 |
| 14 | ICK | 2.18133811 |
| 15 | BCKDK | 2.02129529 |
| 16 | PTK6 | 1.97684018 |
| 17 | NME2 | 1.96572927 |
| 18 | FGFR4 | 1.93620709 |
| 19 | MAP3K7 | 1.74573487 |
| 20 | EEF2K | 1.71841056 |
| 21 | DAPK2 | 1.70178967 |
| 22 | MAP3K10 | 1.63261927 |
| 23 | ARAF | 1.61325434 |
| 24 | STK38 | 1.57663801 |
| 25 | PHKG1 | 1.54775827 |
| 26 | PHKG2 | 1.54775827 |
| 27 | MET | 1.42508321 |
| 28 | MAP3K9 | 1.40492789 |
| 29 | TYRO3 | 1.37954092 |
| 30 | PDGFRA | 1.34971318 |
| 31 | CAMK1G | 1.34918101 |
| 32 | KSR2 | 1.27281545 |
| 33 | TAOK2 | 1.25979560 |
| 34 | CDK12 | 1.25357780 |
| 35 | MAP2K4 | 1.24279509 |
| 36 | CAMKK1 | 1.24249035 |
| 37 | PAK6 | 1.22989626 |
| 38 | TAOK1 | 1.22218138 |
| 39 | SIK2 | 1.19850565 |
| 40 | PDK2 | 1.16021001 |
| 41 | OBSCN | 1.12103353 |
| 42 | EPHB1 | 1.11481757 |
| 43 | PAK4 | 1.10905521 |
| 44 | RET | 1.10421107 |
| 45 | LATS1 | 1.02185581 |
| 46 | BMX | 0.99884864 |
| 47 | BRAF | 0.98731720 |
| 48 | MOS | 0.97822392 |
| 49 | PTK2 | 0.97411004 |
| 50 | CAMK1D | 0.97216889 |
| 51 | WNK4 | 0.95705942 |
| 52 | LMTK2 | 0.95147897 |
| 53 | MAP3K11 | 0.94825204 |
| 54 | SGK3 | 0.94100518 |
| 55 | PDPK1 | 0.93134219 |
| 56 | NTRK1 | 0.92521095 |
| 57 | PRKCH | 0.92203974 |
| 58 | IRAK2 | 0.91824142 |
| 59 | MTOR | 0.90947601 |
| 60 | DDR2 | 0.90635936 |
| 61 | PDK1 | 0.89274722 |
| 62 | PINK1 | 0.87939111 |
| 63 | PRKD2 | 0.87926337 |
| 64 | MAP2K3 | 0.86183282 |
| 65 | MAP3K4 | 0.83580641 |
| 66 | EPHB2 | 0.83570157 |
| 67 | DYRK1B | 0.83333099 |
| 68 | NEK1 | 0.80376572 |
| 69 | RPS6KA2 | 0.79900082 |
| 70 | PTK2B | 0.79090340 |
| 71 | EPHA4 | 0.78921593 |
| 72 | MAP3K2 | 0.73882487 |
| 73 | PAK3 | 0.73731417 |
| 74 | ALK | 0.73628823 |
| 75 | PRKAA1 | 0.73367777 |
| 76 | MAPK12 | 0.72950290 |
| 77 | JAK2 | 0.72527908 |
| 78 | LRRK2 | 0.72314327 |
| 79 | DMPK | 0.71799542 |
| 80 | JAK1 | 0.70057372 |
| 81 | ILK | 0.69877936 |
| 82 | MAPK11 | 0.69633407 |
| 83 | CAMK2G | 0.67629369 |
| 84 | PIK3CG | 0.67594192 |
| 85 | STK11 | 0.67180684 |
| 86 | LATS2 | 0.66060443 |
| 87 | FER | 0.64616242 |
| 88 | MAP3K6 | 0.63451967 |
| 89 | CDK8 | 0.63050334 |
| 90 | TGFBR2 | 0.62091032 |
| 91 | PRKG2 | 0.62063563 |
| 92 | MUSK | 0.60082607 |
| 93 | PRKAA2 | 0.59340359 |
| 94 | WNK1 | 0.58706856 |
| 95 | MAPKAPK3 | 0.57180321 |
| 96 | RPS6KC1 | 0.57040417 |
| 97 | RPS6KL1 | 0.57040417 |
| 98 | MARK2 | 0.56977846 |
| 99 | FGFR2 | 0.56390817 |
| 100 | MST1R | 0.56186971 |
| 101 | CDK6 | 0.55025113 |
| 102 | LIMK1 | 0.54965544 |
| 103 | PAK2 | 0.54508547 |
| 104 | MAP3K8 | 0.54258255 |
| 105 | PIM2 | 0.53846530 |
| 106 | MAP3K3 | 0.53597428 |
| 107 | PDGFRB | 0.52799655 |
| 108 | MAP3K13 | 0.52129515 |
| 109 | PRKCZ | 0.51674988 |
| 110 | NTRK2 | 0.51605570 |
| 111 | FGFR3 | 0.51566877 |
| 112 | PRKD1 | 0.51039418 |
| 113 | NTRK3 | 0.50612882 |
| 114 | MAP2K1 | 0.50055609 |
| 115 | MAP2K6 | 0.49898426 |
| 116 | GRK6 | 0.49288742 |
| 117 | MINK1 | 0.48115931 |
| 118 | SCYL2 | 0.47111796 |
| 119 | CAMK2B | 0.46933663 |
| 120 | FGFR1 | 0.46280725 |
| 121 | MAP3K1 | 0.46227107 |
| 122 | CDC42BPA | 0.45609496 |
| 123 | MAP2K2 | 0.44125146 |
| 124 | RPS6KB2 | 0.43683582 |
| 125 | INSRR | 0.43582513 |
| 126 | ABL2 | 0.41736187 |
| 127 | RPS6KA3 | 0.41048128 |
| 128 | ERBB2 | 0.40110868 |
| 129 | CDK5 | 0.40090491 |
| 130 | MARK1 | 0.39941376 |
| 131 | PRKCI | 0.37668948 |
| 132 | AKT2 | 0.37512608 |
| 133 | HIPK2 | 0.36542016 |
| 134 | RPS6KA6 | 0.35840955 |
| 135 | GSK3A | 0.35559192 |
| 136 | CAMK4 | 0.35130395 |
| 137 | TESK1 | 0.34489843 |
| 138 | SGK1 | 0.33738115 |
| 139 | DAPK3 | 0.33100543 |
| 140 | MAPK4 | 0.30913760 |
| 141 | ROCK2 | 0.30862962 |
| 142 | TBK1 | 0.30860033 |
| 143 | MAPK10 | 0.30341697 |
| 144 | CAMK2D | 0.30010302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.92635206 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.57860273 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.05029614 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.89160951 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.39769768 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.31179797 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.19989011 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.11612074 |
| 9 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.03414075 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.98388501 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94912313 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.91299583 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89995001 |
| 14 | Bile secretion_Homo sapiens_hsa04976 | 1.89706468 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.87263124 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.80445120 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76887089 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.72268255 |
| 19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67003045 |
| 20 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.63983114 |
| 21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.52602581 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.50602344 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.49962175 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.46058056 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45358989 |
| 26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.35037142 |
| 27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.31309234 |
| 28 | * Notch signaling pathway_Homo sapiens_hsa04330 | 1.30900268 |
| 29 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.29086385 |
| 30 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.27922354 |
| 31 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.27884999 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.26760335 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.25431858 |
| 34 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.25166501 |
| 35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.23126763 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23058915 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.20764403 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20298239 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 1.20142168 |
| 40 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.19023656 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.17754026 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.16889193 |
| 43 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.16817588 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14756474 |
| 45 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.14374168 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.13084799 |
| 47 | Endometrial cancer_Homo sapiens_hsa05213 | 1.09970912 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09966802 |
| 49 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.08895105 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.08890592 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08653369 |
| 52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.07804730 |
| 53 | Thyroid cancer_Homo sapiens_hsa05216 | 1.06675318 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06218311 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06149804 |
| 56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.02282007 |
| 57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01858995 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01611305 |
| 59 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.00151027 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 1.00147109 |
| 61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.97950798 |
| 62 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.95936681 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93729074 |
| 64 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92976604 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92109380 |
| 66 | Adherens junction_Homo sapiens_hsa04520 | 0.90528777 |
| 67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.88426979 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.84680732 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84050129 |
| 70 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83138484 |
| 71 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81067002 |
| 72 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.80968707 |
| 73 | Tight junction_Homo sapiens_hsa04530 | 0.80686936 |
| 74 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78866914 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72507827 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72390142 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71905724 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70533726 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70460405 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69620284 |
| 81 | Axon guidance_Homo sapiens_hsa04360 | 0.69297204 |
| 82 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69122367 |
| 83 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68729971 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68260983 |
| 85 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68151222 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68130313 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67942706 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67519721 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.67212406 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67174596 |
| 91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66650415 |
| 92 | * Melanogenesis_Homo sapiens_hsa04916 | 0.66641389 |
| 93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66583569 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65716736 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65670206 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.63167878 |
| 97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62928554 |
| 98 | Gap junction_Homo sapiens_hsa04540 | 0.61968282 |
| 99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59913374 |
| 100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59307441 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59283326 |
| 102 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59220790 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57594542 |
| 104 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.56661597 |
| 105 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.55624617 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55536123 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55355311 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54706803 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54317995 |
| 110 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54039894 |
| 111 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53786996 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53249013 |
| 113 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.52664199 |
| 114 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52590408 |
| 115 | * Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52203219 |
| 116 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51428194 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51300438 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51057519 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50244697 |
| 120 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49620076 |
| 121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47898929 |
| 122 | Salivary secretion_Homo sapiens_hsa04970 | 0.47880822 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45097270 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44775823 |
| 125 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.44588830 |
| 126 | Insulin secretion_Homo sapiens_hsa04911 | 0.44196975 |
| 127 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42608084 |
| 128 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40421834 |
| 129 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39660211 |
| 130 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.39530126 |
| 131 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38774985 |
| 132 | Renin secretion_Homo sapiens_hsa04924 | 0.38217819 |
| 133 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37544826 |
| 134 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37371128 |
| 135 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34831058 |
| 136 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.34800645 |
| 137 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.34578937 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34478005 |
| 139 | Long-term potentiation_Homo sapiens_hsa04720 | 0.31327504 |
| 140 | Focal adhesion_Homo sapiens_hsa04510 | 0.30610053 |
| 141 | Prion diseases_Homo sapiens_hsa05020 | 0.30296736 |
| 142 | Glioma_Homo sapiens_hsa05214 | 0.29802738 |
| 143 | Amoebiasis_Homo sapiens_hsa05146 | 0.28922289 |
| 144 | Sulfur relay system_Homo sapiens_hsa04122 | 0.28566500 |
| 145 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28012775 |
| 146 | Olfactory transduction_Homo sapiens_hsa04740 | 0.27972562 |
| 147 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.27889351 |
| 148 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27574889 |
| 149 | Bladder cancer_Homo sapiens_hsa05219 | 0.27294251 |
| 150 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.26825109 |

